Evidence map›Paper›PMID 31173589›Full record

ArticlePloS one2019

Neuropathy-related mutations alter the membrane binding properties of the human myelin protein P0 cytoplasmic tail.

Arne Raasakka, Salla Ruskamo, Robert Barker, Oda C Krokengen, Guro H Vatne, Cecilie K Kristiansen, Erik I Hallin, Maximilian W A Skoda, Ulrich Bergmann, Hanna Wacklin-Knecht and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Arne RaasakkaDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0002-9443-9959
Salla RuskamoFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Robert BarkerSchool of Physical Sciences, University of Kent, Kent, United Kingdom.ORCID 0000-0002-8645-5385
Oda C KrokengenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Guro H VatneDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Cecilie K KristiansenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Erik I HallinDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Maximilian W A SkodaISIS Neutron and Muon Source, Science & Technology Facilities Council, Rutherford Appleton Laboratory, Didcot, United Kingdom.
Ulrich BergmannFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Hanna Wacklin-KnechtDivision of Physical Chemistry, Department of Chemistry, Lund University, Lund, Sweden.
Nykola C JonesISA, Department of Physics and Astronomy, Aarhus University, Aarhus C, Denmark.ORCID 0000-0002-4081-6405
Søren V HoffmannISA, Department of Physics and Astronomy, Aarhus University, Aarhus C, Denmark.
Petri KursulaDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-8529-3751
University of Bergen · NOAarhus University · DKUniversity of Oulu · FILund University · SERutherford Appleton Laboratory · GBUniversity of Kent · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schwann cells myelinate selected axons in the peripheral nervous system (PNS) and contribute to fast saltatory conduction via the formation of compact myelin, in which water is excluded from between tightly adhered lipid bilayers. Peripheral neuropathies, such as Charcot-Marie-Tooth disease (CMT) and Dejerine-Sottas syndrome (DSS), are incurable demyelinating conditions that result in pain, decrease in muscle mass, and functional impairment. Many Schwann cell proteins, which are directly involved in the stability of compact myelin or its development, are subject to mutations linked to these neuropathies. The most abundant PNS myelin protein is protein zero (P0); point mutations in this transmembrane protein cause CMT subtype 1B and DSS. P0 tethers apposing lipid bilayers together through its extracellular immunoglobulin-like domain. Additionally, P0 contains a cytoplasmic tail (P0ct), which is membrane-associated and contributes to the physical properties of the lipid membrane. Six CMT- and DSS-associated missense mutations have been reported in P0ct. We generated recombinant disease mutant variants of P0ct and characterized them using biophysical methods. Compared to wild-type P0ct, some mutants have negligible differences in function and folding, while others highlight functionally important amino acids within P0ct. For example, the D224Y variant of P0ct induced tight membrane multilayer stacking. Our results show a putative molecular basis for the hypermyelinating phenotype observed in patients with this particular mutation and provide overall information on the effects of disease-linked mutations in a flexible, membrane-binding protein segment. Using neutron reflectometry, we additionally show that P0ct embeds deep into a lipid bilayer, explaining the observed effects of P0ct on the physical properties of the membrane.

Indexed as

MutationCell MembraneCytoplasmHumansLipid BilayersMyelin P0 ProteinPeripheral Nervous System DiseasesPhenotypeProtein BindingProtein FoldingLipid BilayersMyelin P0 Protein

Identifiers

PMID31173589
PMCPMC6555526
OpenAlexW2914047661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.